6. Researches, discoveries and innovations in Russia

As a result of implementing the project, in 2010-2015 RUSNANO Russian company will establish original commercial production of medications that are without parallel in the entire world. The unique technology for fusing the most dissimilar drug substances in phospholipid nanoparticles was developed in the Russian Federation. It will enable the project company to enter the market with innovative and highly effective forms of medications in only one to two years, with minimal risk, and with a minimal budget.

The capsules of drug nanoparticles (micelles) are composed of phospholipids—natural fat molecules that form in cell membranes. Phospholipid nanoparticles easily penetrate the cells and free the active drug ingredients precisely where they are needed. Phagocytes and other cells of the human defense system that imbibe objects foreign to the organism are unable to distinguish the 15-nm to 25-nm drug nanoparticles. Therefore, the nanoparticles circulate in the blood stream longer and leave it largely in those places where the vessel walls are most penetrable. Those most penetrable places—for example, the locus of inflammation or tumor—often require therapeutic intervention.

Drug production and supplies to the drug delivery system is an innovative area of the pharmaceutical industry worldwide. The first series of drugs are expected to enter production and sale in 2011-2012. These will be nanoforms of indometacin (a non-steroid anti-inflammatory drug), prednisolone (a steroid anti-inflammatory drug), and chlorine-E6 (an active ingredient in photosensitizers—medications used to treat a long list of illnesses in oncology, otolaryngology, dermatology, dentistry, and surgery with an innovative method of photodynamic therapy.) In the second series of medication, 2012-2015, the project company plans to issue nanoforms of verospiron (a potassium-sparing diuretic) and the innovative statin nanophospholip (a drug that decreases the level of cholesterol in the blood and helps fight cardiovascular diseases).

7. Prospects of work in my professional field

I have decided to connect my future life with science mainly because I am interested in research. I’m an engineer by profession and I have to conduct research in this sphere. Heat and power engineering is an area of power-engineering dealing with energy generation and energy transformation laws. The problem of the rational energy use in technological process is one of the most important now. Its solution defines a standard of living and future prospects.  As market relations in Russian economy and industry are developing and companies are entering the world market, the role of power supply and ecology in the industrial effectiveness will increase. 

Deep awareness in the thermal physic theory of all processes and energy laws allows solve complicated problems of energy supply for different sectors of economy, to develop and implement high-performance equipment and technological processes in order to solve contemporary issues of energy supply. Every graduate in the specialization “Heat-and-power engineering” has so many prospects in their carrier ladder. The young specialists can realized themselves in design organizations as well as in generating companies. Currently not many young people want to work as engineers and develop our power industry. But for me it’s interesting and I want to work in the field of my specialization. And I hope my job will help to support our hydroelectric power stations in good modern conditions.